Ads
related to: Macular Degeneration Treatment- Wet AMD FAQs
Get Answers To Frequently Asked
Questions About Wet AMD
- Appointment Tips
Get Tips And Useful Information
To Talk to your Retina Specialist
- Clinical Study Results
See The Results of A Clinical Study
To Learn More About This Treatment
- Financial Assistance
Learn About Financial Support
That May Be Available To You
- Wet AMD FAQs
Search results
Age-Related Macular Degeneration: Putting a Hole in Our World
WebMD· 6 hours agoWhen we’re young, we take our macula for granted. At the center of our retina – the deepest layer of the eye that’s chock-full of photoreceptors and that confers color to our world – the macula ...
Earnings call: Lineage Cell Therapeutics reports positive OpRegen trial results By Investing.com
Investing.com· 3 hours agoIn a recent earnings call, Lineage Cell Therapeutics (NYSE:LCTX), a biotechnology company...
Lineage Cell Therapeutics Q1 2024 Earnings: Aligns with EPS Projections Amidst Revenue Declines
GuruFocus.com via Yahoo Finance· 2 hours agoThe company also reported positive long-term data from its OpRegen treatment, showing sustained visual benefits, which underscores the therapys potential in treating geographic ...
The American Macular Degeneration Foundation Showc | Newswise
Newswise· 2 days ago“Our goal is to advance the development of treatments, tools and usable information that improve the lives of those affected by AMD and, just as important, a sense of hope ...
Kyowa Kirin Will Present Pre-Clinical Data at the Association for Research in Vision and...
Char-Koosta News· 2 days agoAge-related macular degeneration (AMD) is a leading cause of severe vision loss for people aged 50 years and older in developed countries worldwide, with ...
EyePoint Pharmaceuticals Q1 2024 Earnings: Revenue Surpasses Estimates Despite Challenges
GuruFocus.com via Yahoo Finance· 4 hours agoThe company utilizes its proprietary Durasert E and Verisome technology platforms to develop ...
Adverum Biotechnologies Reports Q1 2024 Results: A Detailed Look at Financials and Pipeline Progress
GuruFocus.com via Yahoo Finance· 3 hours agoIts flagship product, ADVM-022 (Ixo-vec), aims to revolutionize care for patients with wet age-related macular degeneration (AMD) by reducing the frequency ...
EyePoint Pharmaceuticals’ stock plunges as eye treatment fails to meet trial goal
Market Watch· 4 days agodropped nearly 30% in premarket trading Monday after the company said its experimental...
These 2 ‘Strong Buy’ Penny Stocks Could Surge Over 400%, Says Oppenheimer
TipRanks via Yahoo Finance· 1 day agoRisk and reward are the yin and yang of stock trading, the two essential yet opposing forces in...
EyePoint reports mixed results in diabetic retinopathy trial By Investing.com
Investing.com· 4 days agoEyePoint Pharmaceuticals, Inc. (NASDAQ: NASDAQ:EYPT) announced interim results from its Phase 2...
Ad
related to: Macular Degeneration Treatment